Abstract
AbstractNatriuretic peptides (NP) have multiple actions benefitting cardiovascular and metabolic health. Although many of these are mediated by Guanylyl Cyclase (GC) receptors NPR1 and NPR2, their role and relative importance in vivo is unclear. The intracellular mediator of NPR1 and NPR2, cGMP, circulates in plasma and can be used to examine relationships between receptor activity and tissue responses targeted by NPs. Plasma cGMP was measured in 348 participants previously recruited in a multidisciplinary community study (CHALICE) at age 50 years at a single centre. Associations between bio-active NPs and bio-inactive aminoterminal products with cGMP, and of cGMP with tissue response, were analysed using linear regression. Mediation of associations by NPs was assessed by Causal Mediation Analysis (CMA). ANP’s contribution to cGMP far exceed those of other NPs. Modelling across three components (demographics, NPs and cardiovascular function) shows that ANP and CNP are independent and positive predictors of cGMP. Counter intuitively, findings from CMA imply that in specific tissues, NPR1 responds more to BNP stimulation than ANP. Collectively these findings align with longer tissue half-life of BNP, and direct further therapeutic interventions towards extending tissue activity of ANP and CNP.
Funder
National Heart Foundation of New Zealand
Lottery Health Research
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Kuhn, M. Molecular physiology of membrane guanylyl cyclase receptors. Physiol. Rev. 96, 751–804. https://doi.org/10.1152/physrev.00022.2015 (2016).
2. Hunt, P. J. et al. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Am. J. Physiol. 269, R1397-1403 (1995).
3. Hunt, P. J., Richards, A. M., Espiner, E. A., Nicholls, M. G. & Yandle, T. G. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 78, 1428–1435 (1994).
4. Castro, L. R., Verde, I., Cooper, D. M. & Fischmeister, R. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation 113, 2221–2228. https://doi.org/10.1161/CIRCULATIONAHA.105.599241 (2006).
5. Shotan, A. et al. Plasma cyclic guanosine monophosphate in chronic heart failure: Hemodynamic and neurohormonal correlations and response to nitrate therapy. Clin. Pharmacol. Ther. 54, 638–644. https://doi.org/10.1038/clpt.1993.201 (1993).